American CryoStem to Exhibit at The Aesthetic Meeting
11 Aprile 2013 - 2:30PM
American CryoStem Corporation (OTCQB:CRYO), a
leading biotech company in the field of Regenerative Medicine,
today announced that the Company is scheduled to exhibit at The
Aesthetic Meeting 2013, held this week, April 11-16th in New York
City, at the Jacob Javits Convention Center. The Company will be
showcasing its latest adipose tissue (fat) collection, processing
and storage service, ATGRAFT™ and complimentary personalized skin
care products. With one liposuction, ATGRAFT™ is a complete fat
tissue storage solution for physicians to perform layered fat
transfers and provides patients additional opportunities to use
their stored fat tissue to create personalized skin care products
or clinically processed stem cells for use in Regenerative Medicine
treatments.
This premier event for surgeons, is to learn and be updated on
the latest news, technologies and trends in the cosmetic industry.
These informative sessions are straight from plastic surgeons that
specialize in aesthetic plastic surgery and are on the cutting edge
of new technologies and methodologies. This year is especially
poignant and effective, offering the hottest topics and procedures
in the industry. The week entails ideas in improvement in patient
safety, overall efficiency, with innovative practice and skill
enhancements. The Aesthetic Meeting is hosted by the American
Society for Aesthetic Plastic Surgery (ASAPS), and will disclose
some of the most exciting new developments in the fields of health
and beauty.
If you are a physician and would like to receive information
concerning the conference or American CryoStem's ATGRAFT™ service,
please email info@americancryostem.com, or contact
John DiFolco at 732-747-1007.
EVENT AT A
GLANCE |
|
|
WHO: |
American CryoStem
Corporation |
|
John Arnone – Chairman and CEO |
|
Anthony Dudzinski – COO |
|
|
WHEN: |
Thursday, April 11, 2013 – Tuesday, April
16, 2013 |
|
|
WHERE: |
Booth #968 |
|
Jacob Javits Convention Center |
|
655 W 34th Street |
|
New York, New York 10001 |
|
|
NOTE TO PRESS: |
The media also is invited to attend the
event on a complimentary basis. Please contact; Adeena Babbitt
or Ashley Barton at 800-364-2147 or
media@surgery.org to register for the
event. To arrange one-on-one interviews with the
executive management team of American CryoStem, please contact Erin
Palmer at Hanover|Elite at 407-585-1080 or via email at
CRYO@hanoverelite.com. |
About American CryoStem Corporation
A pioneer in the fields of Regenerative and Personalized
Medicine, American CryoStem is a developer, marketer and global
licensor of patented adipose tissue based cellular technologies and
related proprietary services with a focus on clinical processing,
commercial bio-banking and application development for adipose
(fat) tissue and autologous adipose-derived regenerative cells
(ADRCs). The Company maintains a strategic portfolio of
intellectual property and patent applications that form its Adipose
Tissue Processing Platform, which supports and promotes a growing
pipeline of biologic products and processes, clinical services and
international licensing opportunities. Through its ACS
Laboratories division, the Company operates an FDA registered, cGMP
compliant human tissue processing, cryo-storage and cell culture
and differentiation media development facility in Mount Laurel, New
Jersey. For more information, please visit
www.americancryostem.com and
www.acslaboratories.com.
CONTACT: Hanover|Elite
Jim Hock or Dodi Handy
407-585-1080 or via email at CRYO@hanoverelite.com
Grafico Azioni American Cryostem (CE) (USOTC:CRYO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni American Cryostem (CE) (USOTC:CRYO)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a American Cryostem Corporation (CE) (OTCMarkets): 0 articoli recenti
Più American CryoStem Corp. Articoli Notizie